2 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Secukinumab Injection: new trials by email Literature Review of Secukinumab Injection trials Research Report on Secukinumab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IL-17 Blockade to Decrease irAEs (REPLAY) Secukinumab Injection - Metastatic Melanoma | Phase 1 | Recruiting | Duke University | 4 | 2026-03-12 | 2026-06-04 |
| Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients BAT2306, EU-approved Cosentyx - Plaque Psoriasis | Phase 3 | Completed | Bio-Thera Solutions | 502 | 2022-10-26 | 2025-04-23 |
| Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital. Secukinumab Injection - Plaque Psoriasis | Phase 4 | Completed | Jinnah Postgraduate Medical Centre | 50 | 2021-07-05 | 2023-06-07 |
| Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children Secukinumab Injection, Ustekinumab Injection, Dupilumab Injection - Congenital Ichthyosis | Phase 4 | Unknown | National Medical Research Center for Children's Health, Russian Federation | 50 | 2021-03-01 | 2021-08-09 |
Ichthyosis Vulgaris (1) · Melanoma (1) · Netherton Syndrome (1)
Bio-Thera Solutions (1) · Duke University (1) · Jinnah Postgraduate Medical Centre (1) · National Medical Research Center for Children's Health, Russian Federation (1)
China (1) · Pakistan (1) · Russia (1) · United States (1)
April Salama, MD (1) · Faiza I Siddiqui (1) · Min Zheng (1) · Rabia Ghafoor (1)